SPRC

SciSparc is a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system. The company leverages a proprietary CBD-based drug platform to develop treatments for conditions including Tourette syndrome, Alzheimer disease, and autism spectrum disorder.